Daniel Patrick O'Day sold $1.3M of Gilead Sciences (GILD)

Executed Apr 28, disclosed Apr 29, 1 day later.

Value, as filed

$1.3M

10,000 sh across 2 lots

Executed

Apr 28

the trade date, as filed

Disclosed

Apr 29

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Daniel Patrick O'Day Chairman & CEO profile →

Daniel Patrick O'Day (Chairman & CEO) filed 15 Form 4 reports in the trailing twelve months (0 purchases, 15 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $19.7M of GILD (112,429 sh across 2 lots, as filed), executed Nov 4.

The name

GILD

Gilead Sciences, Inc. GILD · Healthcare · 88 filings in 24 months ticker →

Healthcare · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Daniel Patrick O'Day in GILD

GILDSALE Gilead Sciences, Inc. $19.7M
112,429 sh across 2 lots
Exec Nov 4
Filed Nov 6 · 5:15 PM ET GILDSALE Gilead Sciences, Inc. $5.3M
30,881 sh across 6 lots
Exec Oct 30
Filed Nov 2 · 7:14 PM ET GILDSALE Gilead Sciences, Inc. $2.2M
15,000 sh across 2 lots
Exec Oct 1
Filed Oct 2 · 4:40 PM ET GILDSALE Gilead Sciences, Inc. $2.2M
15,000 sh across 3 lots
Exec Sep 1
Filed Sep 2 · 4:12 PM ET GILDSALE Gilead Sciences, Inc. $1.9M
14,400 sh across 2 lots
Exec Aug 3
Filed Aug 4 · 5:40 PM ET GILDSALE Gilead Sciences, Inc. $1.9M
15,000 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 4:14 PM ET GILDSALE Gilead Sciences, Inc. $2.0M
15,000 sh across 3 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $1.4M
10,000 sh × $136.82
Exec Mar 27
Filed Mar 30 · 5:30 PM ET